Allergan News

Allergan Announces Global Recall of Textured Breast Implants

Allergan Plc said on Wednesday it was recalling its Biocell textured breast implants and tissue expanders across markets, citing concerns over a rare form of cancer, after the U.S. health agency asked the drugmaker to pull the products. The Food …

Supreme Court Denies Drug Maker’s Use of Native American Tribe to Shield Patents

The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc’s unorthodox bid to shield patents from a federal administrative court’s review by transferring them to a Native American tribe. The justices left in place a lower court ruling …

Big Pharma Resuming U.S. Price Hikes in January After Pause: Reuters Report

Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry under pressure from the Trump …

One Drugmaker Sues Another to Pay Damages from Opioid Marketing Lawsuits

Allergan Plc on Thursday sued Pfizer Inc. to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bought. …

Judge Sends Oklahoma’s Lawsuit Against Opioid Makers Back to State Court

U.S. judge has determined that a lawsuit the state of Oklahoma filed against the makers of opioids does not “necessarily rise” to a federal issue. The ruling by U.S. District Judge Vicki Miles-LaGrange in Oklahoma City sends the matter back …

Indianapolis Sues Several Opioid Makers, Distributors

The city of Indianapolis sued several manufacturers and distributors of prescription painkillers in federal court on Nov. 14, alleging that their actions are to blame for the city’s growing opioid crisis. The lawsuit contends that the “dramatic increase” in painkiller …

More Drug Companies Vow to Limit Price Increases

Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent – but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday …

Delaware Chancery Court Allows Derivative Suit Vs. Botox Directors

Directors of Allergan Inc. must face a lawsuit over $600 million in fines the company paid for misbranding its Botox treatment to smooth out wrinkles, a Delaware judge ruled, in a decision that could affect securities litigation in that state. …